Palatin Technologies Inc (PTN): Shareholders' Equity
$6.69M
As of 2026-06-30
$2.03M
As of 2026-09-30
-33.0%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $6.69M | n/m | 2026-09-28, Balance as of period end |
| 2025-06-30 | -$4.78M | n/m | 2026-09-28, Balance as of period end |
| 2024-06-30 | -$111.5K | n/m | 2025-09-23, Balance as of period end |
| 2023-06-30 | -$1.98M | n/m | 2024-09-30, Balance as of period end |
| 2022-06-30 | $16.27M | -67.2% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $49.65M | -38.1% | 2022-09-22, Balance as of period end |
| 2020-06-30 | $80.17M | -20.3% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $100.55M | +272.9% | 2020-09-25, Balance as of period end |
| 2018-06-30 | $26.96M | n/m | 2020-09-25, Balance as of period end |
| 2017-06-30 | -$5.16M | n/m | 2020-09-25, Balance as of period end |
| 2016-06-30 | -$17.59M | n/m | 2018-09-13, Balance as of period end |
| 2015-06-30 | $12.20M | +24.7% | 2017-09-25, Balance as of period end |
| 2014-06-30 | $9.79M | -57.4% | 2016-09-19, Balance as of period end |
| 2013-06-30 | $22.98M | n/m | 2015-09-18, Balance as of period end |
| 2012-06-30 | $1.83M | -89.9% | 2014-09-12, Balance as of period end |
| 2011-06-30 | $18.19M | +95.2% | 2013-09-27, Balance as of period end |
| 2010-06-30 | $9.32M | n/a | 2012-09-10, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | $6.69M | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | $245.15M | +75.7% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $205.57M | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | $1.47M | -18.2% |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | $53.41M | -55.8% |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$63.61M | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | $76.58M | -21.4% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $15.35M | +128.3% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $68.64M | -47.8% |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗